stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
無料 - Play StoreApp Store
インストールインストール
logo
Dow:  
Nasdaq:  
S&P 500:  
Neuroone Medical Technologies CorpNMTC
$0.92724.39%-0.0426

Neuroone Medical Technologies Corp (NMTC)

Date: 2026-10-30 16:00O: 0.9700H: 1.0188L: 0.8700C: 0.9272Vol: 33.83k
前日終値:
$0.9698
開ける：
$0.97
24時間の取引高:
33,825
相対出来高:
0.39
時価総額：
$8.44M
収益：
$9.19M
当期純損益:
-$6.94M
株価収益率:
-
EPS:
-$0.8317
ネットキャッシュフロー:
-$7.57M
1W パフォーマンス:
+15.34%
1M パフォーマンス:
-17.21%
6M パフォーマンス:
-78.69%
1Y パフォーマンス:
-80.49%
1日の値動き範囲:
$0.00$0.00
1週間の範囲:
$0.804$1.04
52週間の値動き範囲:
$0.7719$6.12

Neuroone Medical Technologies Corp（NMTC）会社概要

名前
Neuroone Medical Technologies Corp
セクター
Healthcare
産業
Medical Devices
電話
(952) 426-1383
住所
7599 ANAGRAM DR, EDEN PRAIRIE, USA
職員
18
X
-
次回の収益日
2026-12-15
最新のSEC提出書
SEC
XでのNMTCに関するディスカッション
X

NMTC と ABT, MDT, SYK, BSX, EW を比較

株式時価総額収益当期純利益現金流量EPS
NMTC
Neuroone Medical Technologies Corp
$8.44M$9.19M-$6.94M-$7.57M-$0.8317
ABT
Abbott Laboratories
$183.77B$46.59B$5.41B$7.38B$3.09
MDT
Medtronic Plc
$123.49B$36.36B$4.84B$5.43B$3.73
SYK
Stryker Corp
$111.95B$25.27B$3.34B$4.57B$8.63
BSX
Boston Scientific Corp
$60.84B$20.62B$3.56B$3.48B$2.38
EW
Edwards Lifesciences Corp
$53.03B$6.30B$1.07B$1.09B$1.84

Neuroone Medical Technologies Corp (NMTC) アップグレードとダウングレード

日付アクションアナリスト評価の変更
2025-05-05開始されましたLadenburg ThalmannBuy
2022-03-29ダウングレードCraig HallumBuy → Hold

Neuroone Medical Technologies Corp (NMTC) 財務データ

期間トレンドFY 2025FY 2024FY 2023FY 2022FY 2021
期間終了日2025-09-302024-09-302023-09-302022-09-302021-09-30
Revenue USD (M)9.103.451.950.170.18
Cost of revenue USD (M)3.962.371.500.240.28
Gross profit USD (M)5.141.080.46-0.07-0.10
Research and development USD (M)4.985.076.944.933.93
Operating expenses USD (M)12.3712.9713.8711.9110.19
Operating income USD (M)-4.23-11.89-11.96-10.03-10.22
Income before tax USD (M)-3.61-12.32-11.860.170.18
Income tax expense USD (M)-----0.27
Net income USD (M)-3.61-12.32-11.86-10.00-9.95
Basic EPS USD/shares-0.09-0.46-0.65-0.63-
Diluted EPS USD/shares-0.09-0.46-0.65-0.63-
Basic weighted shares shares (M)40.1526.7618.1216.00-
Diluted weighted shares shares (M)40.1526.7618.1216.00-
Selling, general and administrative USD (M)7.387.906.936.98-

Neuroone Medical Technologies Corp (NMTC) インサイダートレーディング

  • Christianson MarkJun 30 '26
    Market Development Director
    取引
    Sale
    コスト
    $3.18
    #株式
    10,000
    値 ($)
    31,773
    #株式総数
    20,692
  • Christianson MarkJun 30 '26
    Officer
    取引
    Proposed Sale
    コスト
    $3.34
    #株式
    10,000
    値 ($)
    33,400
    #株式総数
    0
  • Christianson MarkMar 30 '26
    Business Development Director
    取引
    Sale
    コスト
    $0.74
    #株式
    15,363
    値 ($)
    11,369
    #株式総数
    198,920
  • Christianson MarkMar 13 '26
    Business Development Director
    取引
    Sale
    コスト
    $0.8
    #株式
    100
    値 ($)
    80
    #株式総数
    214,283
  • Christianson MarkMar 12 '26
    Business Development Director
    取引
    Sale
    コスト
    $0.8
    #株式
    817
    値 ($)
    654
    #株式総数
    214,383
  • Christianson MarkMar 11 '26
    Business Development Director
    取引
    Sale
    コスト
    $0.8
    #株式
    2,109
    値 ($)
    1,687
    #株式総数
    215,200
  • Christianson MarkMar 10 '26
    Business Development Director
    取引
    Sale
    コスト
    $0.8
    #株式
    11,611
    値 ($)
    9,289
    #株式総数
    217,309
  • Christianson MarkMar 09 '26
    Officer
    取引
    Proposed Sale
    コスト
    $0.84
    #株式
    30,000
    値 ($)
    25,200
    #株式総数
    0
  • Wambeke David J.Mar 01 '26
    Chief Business Officer
    取引
    Buy
    コスト
    $0.67
    #株式
    1,000,000
    値 ($)
    670,400
    #株式総数
    1,000,000
インサイダートレーディング関係日付取引コスト#株式値 ($)#株式総数
Christianson MarkMarket Development DirectorJun 30 '26Sale$3.1810,00031,77320,692
Christianson MarkOfficerJun 30 '26Proposed Sale$3.3410,00033,4000
Christianson MarkBusiness Development DirectorMar 30 '26Sale$0.7415,36311,369198,920
Christianson MarkBusiness Development DirectorMar 13 '26Sale$0.810080214,283
Christianson MarkBusiness Development DirectorMar 12 '26Sale$0.8817654214,383
Christianson MarkBusiness Development DirectorMar 11 '26Sale$0.82,1091,687215,200
Christianson MarkBusiness Development DirectorMar 10 '26Sale$0.811,6119,289217,309
Christianson MarkOfficerMar 09 '26Proposed Sale$0.8430,00025,2000
Wambeke David J.Chief Business OfficerMar 01 '26Buy$0.671,000,000670,4001,000,000

Neuroone Medical Technologies Corp (NMTC) 最新ニュース

Oct 08, 2026

A roughly $1 million NIH grant backs research to track brain chemicals in real time - Stock Titan

Oct 08, 2026
May 19, 2017

Saba Capital Income & Opportunities Fund II (SABA) Stock Price, News, Quote & History - Yahoo! Finance Canada

May 19, 2017
Sep 25, 2026

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split - Yahoo Finance

Sep 25, 2026
Sep 10, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Sep 10, 2026
Sep 10, 2026

NeuroOne at Moody Capital conference: thin-film platform aims for growth - Investing.com

Sep 10, 2026
Sep 10, 2026

NeuroOne at Moody Capital conference: thin-film platform aims for growth - Investing.com UK

Sep 10, 2026
Sep 09, 2026

NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Australia

Sep 09, 2026
Sep 08, 2026

NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Nigeria

Sep 08, 2026
Sep 08, 2026

NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com

Sep 08, 2026
Sep 08, 2026

NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com India

Sep 08, 2026
Sep 08, 2026

NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com

Sep 08, 2026
Sep 08, 2026

NeuroOne Medical (NMTC) exec buys shares and receives 35,000 options - Stock Titan

Sep 08, 2026
Sep 08, 2026

NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com South Africa

Sep 08, 2026
Sep 02, 2026

BioRestorative Therapies Announces Reverse Stock Split - Yahoo Finance

Sep 02, 2026
Aug 28, 2026

NeuroOne (NMTC) CFO gets 35,000 options at $1.77 - Stock Titan

Aug 28, 2026
Aug 28, 2026

NeuroOne (NMTC) grants officer options at $1.77 - Stock Titan

Aug 28, 2026
Aug 28, 2026

Neuroone Medical Technologies Corp (NASDAQ: NMTC) Stock Price, News & Analysis - kalkine.ca

Aug 28, 2026
Aug 28, 2026

NeuroOne Medical (NMTC) grants CTO 15,000 options vesting from 2027 - Stock Titan

Aug 28, 2026
Aug 28, 2026

NeuroOne Medical (NMTC) CEO granted 68K stock options - Stock Titan

Aug 28, 2026
Aug 28, 2026

NeuroOne Medical (NMTC) CAO awarded 12,500 stock options - Stock Titan

Aug 28, 2026
Aug 28, 2026

NeuroOne Medical | 4: Statement of changes in beneficial ownership of securities-Officer Rosa David A - Moomoo

Aug 28, 2026
Aug 27, 2026

Neuroone Medical Technologies Corp (NMTC) Key Financial Ratios – Valuation, Profitability & More - Value Research

Aug 27, 2026
Aug 27, 2026

NeuroOne Expects First StereoCED Revenue in Current Quarter - minichart.com.sg

Aug 27, 2026
Aug 27, 2026

NeuroOne reports successful large-animal StereoCED procedures, expects related revenue in Q4 2026 - TradingView

Aug 27, 2026
Aug 27, 2026

NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform - Yahoo Finance

Aug 27, 2026
Aug 20, 2026

NeuroOne (NMTC) Q3 2026 Earnings Call Transcript - The Globe and Mail

Aug 20, 2026
Aug 18, 2026

JonesTrading Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $8 - Moomoo

Aug 18, 2026
Aug 18, 2026

NeuroOne Medical Technologies (NasdaqCM:NMTC) Stock Forecast & Analyst Predictions - Simply Wall Street

Aug 18, 2026
Aug 17, 2026

NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Cal - GuruFocus

Aug 17, 2026
Aug 16, 2026

Neuroone Medical earnings missed by $0.10, revenue fell short of estimates - Investing.com

Aug 16, 2026
Aug 14, 2026

NMTC Maintained by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus

Aug 14, 2026
Aug 14, 2026

NeuroOne (NMTC) Earnings Call zum 3. Quartal des Geschäftsjahres 2026: Aufträge steigen um 43 %, Marge erreicht 59,9 % - TradingKey

Aug 14, 2026
Aug 14, 2026

Nerdy Inc. Announces 1-For-15 Reverse Stock Split - Yahoo Finance

Aug 14, 2026
Aug 13, 2026

NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Yahoo Finance

Aug 13, 2026
Aug 13, 2026

Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall - Investing.com

Aug 13, 2026
Aug 13, 2026

Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Australia

Aug 13, 2026
Aug 13, 2026

Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026
Aug 13, 2026

Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow - GuruFocus

Aug 13, 2026
Aug 13, 2026

NEUROONE MEDICAL TECHNOLOGIES Corp 3Q FY2026: Revenue $1.97M, EPS $(0.28) — 10-Q Summary - TradingView

Aug 13, 2026
Aug 13, 2026

Q3 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus

Aug 13, 2026
Aug 13, 2026

Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Canada

Aug 13, 2026
Aug 13, 2026

Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com India

Aug 13, 2026
Aug 13, 2026

Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com UK

Aug 13, 2026
Aug 13, 2026

NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9% - TradingView

Aug 13, 2026
Aug 13, 2026

NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk - Stock Titan

Aug 13, 2026
Aug 13, 2026

NeuroOne Fiscal Q3 2026 Earnings: Gross Margin Expands as Net Loss Widens - TradingKey

Aug 13, 2026
Aug 13, 2026

NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - Yahoo Finance

Aug 13, 2026
Aug 13, 2026

NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - The Globe and Mail

Aug 13, 2026
Aug 11, 2026

NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification - Yahoo Finance

Aug 11, 2026
Aug 11, 2026

SolarMax Technology Announces Reverse Stock Split to Support Effort to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement - Yahoo Finance

Aug 11, 2026

NMTCに類似

BMRABMRA$1.721.15%PLSMPLSM$1.673.09%VNRXVNRX$0.19531.11%INBSINBS$1.763.83%TNONTNON$2.0510.48%BDMDBDMD$0.160414.68%